CMS Reverses the Reimbursement for AVASTIN

- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - https://eyedocnews.com -

Posted By Irv Arons On November 17, 2009 @ 8:29 am In Industry News,Macular Degeneration,Products,Retina | Comments Disabled

In a move in response to the pressure of the AAO and several other ophthalmic groups, the CMS has rescinded Code Q2024 about reimbursement for Avastin. Reimbursement now reverts back to the original pre-October 1st policy of $50 per dose.

For more, see my writeup ^[1] posted this morning on my online Journal.

Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: https://eyedocnews.com

URL to article: https://eyedocnews.com/002608-cms-reverses-the-reimbursement-for-avastin/

URLs in this post:

[1] my writeup: http://tinyurl.com/AvastinUpdate35

Click here to print.